US 12409224
Compositions and methods for the treatment of VEN/AZA resistant acute myeloid leukemia
granted A61KA61K40/11A61K40/15
Quick answer
US patent 12409224 (Compositions and methods for the treatment of VEN/AZA resistant acute myeloid leukemia) held by The Regents of the University of Colorado, a Body Corporate expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Sep 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K40/11, A61K40/15, A61K40/31, A61K40/421